Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2496579A1 1-substituted 2-azabicyclo [3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
09/12/2012EP2496568A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
09/12/2012EP2496555A1 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
09/12/2012EP2496249A2 Glp-1 receptor agonist compounds for obstructive sleep apnea
09/12/2012EP2496245A2 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
09/12/2012EP2496238A1 Lipid formulated compositions and methods for inhibiting expression of transthyretin (ttr)
09/12/2012EP2496228A2 Methods for treating attention-deficit/hyperactivity disorder
09/12/2012EP2496227A2 Methods for treating fibromyalgia syndrome
09/12/2012EP2496226A1 New therapeutic approaches for treating alzheimer disease
09/12/2012EP2496224A1 Methods of treating elevations in mtor signaling
09/12/2012EP2496083A1 Nicotine containing formulation
09/12/2012EP2496079A1 Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
09/12/2012CN102666836A Cell or culture extract of cladonia macilenta purple and/or biruloquinone as acetylcholinesterase inhibitors
09/12/2012CN102666552A Bicyclic thiazoles as allosteric modulators of mglur5 receptors
09/12/2012CN102666551A Bicyclic thiazoles as allosteric modulators of mglur5 receptors
09/12/2012CN102666550A Spiropiperidine compounds as ORL-1 receptor antagonists
09/12/2012CN102666542A Pyrazolopyrimidine derivatives
09/12/2012CN102666540A Condensed azine-derivatives for the treatment of diseases related to the acetylcholine receptor
09/12/2012CN102666511A Crystalline methylthioninium chloride hydrates
09/12/2012CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders
09/12/2012CN102666484A Alpha adrenergic receptor modulators
09/12/2012CN102665744A A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof
09/12/2012CN102665743A Plant extracts for treating neurodegenerative diseases
09/12/2012CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
09/12/2012CN102665721A Use of polysaccharides for treating stress and anxiety
09/12/2012CN102665717A Learning motivation improvers
09/12/2012CN102665710A Agent for inhibiting decrease of visceral fat in patient with Parkinson's disease
09/12/2012CN102665452A Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) -
09/12/2012CN102665451A Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)-
09/12/2012CN102660548A Preparation and application of South China sea conus textile conotoxin TxO10
09/12/2012CN102659951A TAT (Trans-activating factor) kringle domain-modified nenurogenin2 fusion protein, as well as preparation method thereof and application thereof
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102659943A Antibody glycosylation in the variable region
09/12/2012CN102659905A Hederagenin derivative, and preparation method and application thereof
09/12/2012CN102659742A Application of genistein derivative in preparing medicament for treating learning and memory disorder
09/12/2012CN102657874A A hydrogel-encapsulated lentivirus Lingo-1 RNAi complex for repairing nerve injury and a preparation method thereof
09/12/2012CN102657836A Medicine composition used for treating insomnia
09/12/2012CN102657819A Drug combination for treating dysthymic disorder
09/12/2012CN102657806A Combination tablets for dissipating bruise, promoting the circulation of qi, activating yang and removing stasis
09/12/2012CN102657802A Traditional Chinese medicine for treating diabetic feet
09/12/2012CN102657786A Drinking potion for treating mania
09/12/2012CN102657783A Drug for treating involutional psychosis
09/12/2012CN102657777A Medicament for treatment of neurasthenia
09/12/2012CN102657776A Sleep-improving health product
09/12/2012CN102657775A Medicament composition for treating depression
09/12/2012CN102657758A Traditional Chinese medical composition and preparation method and application thereof
09/12/2012CN102657726A Medicament for treating insomnia
09/12/2012CN102657715A Drug combination with function of improving sleep
09/12/2012CN102657713A Medicine for treating vascular dementia disease and preparation method thereof
09/12/2012CN102657701A Face strengthening ointment
09/12/2012CN102657686A Application of sea-buckthorn seed oil to preparation of medicament for preventing and/or treating depression
09/12/2012CN102657685A Application of Ephedra sinica Stapf and aqueous extracts from Ephedra sinica Stapf in preparation of medicines for treating traumatic cerebral strikes
09/12/2012CN102657666A Medical application of 1,2,3,4,6-O-pentagalloylglucose and composition thereof in preparation of demulcent medicaments
09/12/2012CN102657664A Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
09/12/2012CN102657661A Pharmaceutical application of Nestorone in preparing Alzheimer disease
09/12/2012CN102657656A Composition and methods for modulating a kinase cascade
09/12/2012CN102657655A Application of pyrilamine compounds to preparation of acetylcholinesterase inhibitor
09/12/2012CN102657645A Application of matrine in preparing drug for preventing and treating alzheimer disease
09/12/2012CN102657644A Use of nocardamine in preparation of senile dementia-resisting drug
09/12/2012CN102657641A Application of calycosin to preparation of medicine for resisting vascular dementia
09/12/2012CN102657635A Spongy asenapine sublingual film agent with micropores and preparation method thereof
09/12/2012CN102657630A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
09/12/2012CN102657615A Vincamine sustained-release pellet preparation and preparation method thereof
09/12/2012CN102657612A GDNF-carrying microbubble preparation and method for making the same
09/12/2012CN102657604A Oral liquid for treating vertigo and vomitting
09/12/2012CN102657329A Soluble tremella combination drink and preparation method thereof
09/12/2012CN102178778B Medicament for tranquilizing mind, invigorating brain, strengthening body and relieving fatigue and preparation method thereof
09/12/2012CN102151224B Infantile cerebral palsy acupuncture point heat treatment plaster
09/12/2012CN102145114B Novel traditional Chinese medicine for treating cold
09/12/2012CN102133344B Health-care medicinal liquor
09/12/2012CN102058580B New application of 15-oxospiramilactone for inhibition of Wnt signal path
09/12/2012CN101897960B hNgR-Fc fusion protein vaccine for promoting regeneration and functional recovery of central nerves
09/12/2012CN101885735B Phenol hydroxy acid ester substituted phosphate compound, preparation method and application in medicines
09/12/2012CN101805688B Mulberry health-care wine and preparation method thereof
09/12/2012CN101781347B Polymorphic substances of decitabine and medical compositions
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101516373B Medicament for the enhancement of cognitive function and neuroprotection
09/12/2012CN101257900B Gsk-3 inhibitors
09/12/2012CN101125848B A process for preparing duloxetine and intermediates for use therein
09/11/2012US8263650 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263611 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative
09/11/2012US8263609 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands
09/11/2012US8263601 Deuterium substituted xanthine derivatives
09/11/2012US8263597 Indazole compounds as CCR1 receptor antagonists
09/11/2012US8263584 Imidazopyridines
09/11/2012US8263402 Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263128 Solid pharmaceutical dispersions with enhanced bioavailability
09/11/2012US8263121 Solid pharmaceutical preparation
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012US8262054 Furnace mount
09/11/2012CA2699908C Resveratrol-containing compositions for modulating gene product concentration or activity
09/11/2012CA2480881C Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2465245C Biologically active peptides and their use for repairing injured nerves
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 1833